✦ LIBER ✦

A case report of successful alemtuzumab treatment of a B-CLL patient suffering from renal failure

✍ Scribed by F. Haslbauer

Publisher: Springer
Year: 2008
Tongue: English
Weight: 60 KB
Volume: 88
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-008-0630-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful management of acute renal fai

Successful management of acute renal failure with a vaginal pessary: a case report

✍ John P. Micha; Mark A. Rettenmaier; Matthew Clark; Jim C. Hu; Miles Chang; John 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 251 KB

Successful Treatment of anAspergillusBra

Successful Treatment of anAspergillusBrain Abscess with Caspofungin: Case Report of a Diabetic Patient Intolerant of Amphotericin B

✍ A.L. Colombo; R.C. Rosas 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 129 KB

Severe, irreversible renal failure after

Severe, irreversible renal failure after ifosfamide treatment. A clinicopathologic report of two patients

✍ Jeffrey S. Berns; Amir Haghighat; Arthur Staddon; J Raphael M. Cohen; Richard Sc 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 475 KB 👁 1 views

Successful treatment of increased intrac

Successful treatment of increased intracranial pressure by barbiturate therapy in a patient with severe sinus thrombosis after failure of osmotic therapy. A case report

✍ M. Maruishi; H. Kato; H. Nawashiro; H. Takiguchi; K. Shima; H. Chigasaki 📂 Article 📅 1993 🏛 Springer Vienna 🌐 English ⚖ 802 KB

Successful treatment of chronic myeloid

Successful treatment of chronic myeloid leukemia with imatinib mesylate in a patient with chronic renal failure on hemodialysis

✍ Evren Ozdemir; Yener Koc; Emin Kansu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB 👁 2 views

131I treatment of thyroid papillary carc

131I treatment of thyroid papillary carcinoma in a patient with renal failure

✍ Donald W. Morrish; Larry J. Filipow; Alexander J. McEwan; Ronald Schmidt; Keith 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 503 KB

Procedures for 13'1 ablation in renal failure are not known. In one patient receiving dialysis, detailed dosimetry and health safety aspects were obtained. The results showed insignificant contamination of equipment, but a surprisingly significant reduction in biologic half-life of I3'I due to effic